Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-11-29 Purchase | 2022-11-30 7:56 pm | POINT Biopharma Global Inc. | PNT | MCCANN JOE A. Chief Executive Officer | 2,160 | $6.64 | $14,342 | 3,616,313 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-12-22 Equity Swap | 2023-12-27 5:40 pm | N/A N/A | POINT Biopharma Global Inc. | PNT | MCCANN JOE A. Chief Executive Officer | 3,496,313 | $0 | 0 (Direct) | View |
2023-12-27 Disposition | 2023-12-27 5:40 pm | N/A 2028-03-29 | POINT Biopharma Global Inc. | PNT | MCCANN JOE A. Chief Executive Officer | 1,074,438 | $0 | 0 (Direct) | View |
2023-11-06 Gift | 2023-11-07 6:33 pm | N/A N/A | POINT Biopharma Global Inc. | PNT | MCCANN JOE A. Chief Executive Officer | 120,000 | $0 | 3,496,313 (Indirect) | View |
2023-03-28 Option Award | 2023-03-30 8:12 pm | N/A 2029-03-28 | POINT Biopharma Global Inc. | PNT | MCCANN JOE A. Chief Executive Officer | 692,643 | $0 | 692,643 (Direct) | View |
2022-03-29 Option Award | 2022-03-31 4:56 pm | N/A 2028-03-29 | POINT Biopharma Global Inc. | PNT | MCCANN JOE A. Chief Executive Officer | 381,795 | $0 | 381,795 (Direct) | View |
2021-06-30 Option Award | 2021-06-30 9:30 pm | N/A N/A | POINT Biopharma Global Inc. | PNT | MCCANN JOE A. Chief Executive Officer | 3,614,153 | $0 | 3,614,153 (Direct) | View |